MOST TRUSTED NEWSWIRE PRESS RELEASE DISTRIBUTION
PRTODAY / NewswireToday press release distribution service network
More news: Research
Written by / Agency / Source: Frost & Sullivan
Check Ads Availability|e-mail Article

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Frost & Sullivan Honours Merck Serono for its Achievements in the Treatment of Infertility - Merck Serono receives the 2011 Europe Frost & Sullivan Award for Competitive Strategy Leadership in recognition of the success of its comprehensive portfolio of hormone-based therapeutic products
Frost & Sullivan Honours Merck Serono for its Achievements in the Treatment of Infertility

 

NewswireToday - /newswire/ - London, United Kingdom, 2012/01/30 - Merck Serono receives the 2011 Europe Frost & Sullivan Award for Competitive Strategy Leadership in recognition of the success of its comprehensive portfolio of hormone-based therapeutic products.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Research Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Merck Serono receives the 2011 Europe Frost & Sullivan Award for Competitive Strategy Leadership in recognition of the success of its comprehensive portfolio of hormone-based therapeutic products and strategic expansion across European and global infertility treatment markets

Based on its recent analysis of the infertility therapeutics market, Frost & Sullivan recognizes Merck Serono, the pharmaceutical division of Merck KGaA, Darmstadt, Germany, with the 2011 Europe Frost & Sullivan Award for Competitive Strategy Leadership.

The European hormone products market for infertility has been relatively stagnant over a decade with less differentiation in terms of product characteristics and delivery mechanisms. Merck Serono, by virtue of its comprehensive range of innovative and unique products and advanced delivery systems aimed at improving therapeutic efficacy and patient compliance, has managed to stay ahead of its competitors in the European as well as global infertility therapeutics market.

Besides having one of the most varied product portfolios in the infertility therapeutics market, Merck Serono has been making substantial efforts to meet customers’ needs.” said Frost & Sullivan Research Analyst Aiswariya Chidambaram. “This is evident from the development of its new pre-filled, ready-to-use pen injectors for the administration of the three recombinant hormone products needed to treat infertility, which were recently approved by the Health Authorities.”

“Additionally, the company has always been proactive in expanding its global footprint and exploring new market opportunities through strategic alliances with ideal partners in the pharmaceutical and biotechnology industries”, remarks Chidambaram. “Similarly, Merck Serono has always remained pro-active in encouraging and nurturing innovation by funding innovative research projects and launching informative websites for the benefit of the patients.”

Each year, Frost & Sullivan presents this award to the company whose competitive strategy yields significant gains in market share. The recognized company takes advantage of recent market changes that facilitate the introduction of novel methods of capturing and solidifying market presence. Alternatively, the award recipient has executed an innovative strategy within the existing competitive landscape. In either case, the company captures the attention of the competition, which quickly adjusts to protect its own market position. Frost & Sullivan analysts expect such innovations to produce lasting, precedent-setting trends in the industry.

Frost & Sullivan Best Practices awards recognize companies in a variety of regional and global markets for demonstrating outstanding achievement and superior performance in areas such as leadership, technological innovation, customer service and strategic product development. Industry analysts compare market participants and measure performance through in-depth interviews, analysis and extensive secondary research to identify best practices in the industry.

About Frost & Sullivan
Frost & Sullivan (frost.com), the Growth Partnership Company, enables clients to accelerate growth and achieve best-in-class positions in growth, innovation and leadership. The company's Growth Partnership Service provides the CEO and the CEO's Growth Team with disciplined research and best-practice models to drive the generation, evaluation, and implementation of powerful growth strategies. Frost & Sullivan leverages 50 years of experience in partnering with Global 1000 companies, emerging businesses and the investment community from more than 40 offices on six continents.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Research Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Frost & Sullivan

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick NewswireToday Visibility Checker

 

Distribution / Indexing: [+]  / [Company listed above is a registered member of our network. Content made possible by PRZOOM / PRTODAY indexing services]

 
 
# # #
 
 
  Your Banner Ad showing on ALL
Research articles,
CATCH Visitors via Your Competitors Announcements!


Frost & Sullivan Honours Merck Serono for its Achievements in the Treatment of Infertility

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name NewswireToday and LINK as the source.
 
Publisher Contact: Emily Bailey 
+44(0)20 7915 7869 emily.bailey[.]frost.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Frost & Sullivan securities in any jurisdiction including any other companies listed or named in this release.

Research via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Frost & Sullivan / Company Profile


Read Research Most Recent Related Newswires:

Increasing Demand for Real Time Access Boosts the Global Image Recognition Market At 21.00% CAGR According to Inkwood Research
Innovative MYRRHA Research Reactor Starting to Take Shape
BASF and BNP Brinkmann Acting as Project Partners to Support Current DLR Research on the Future of Mobility
BASF and CTIBiotech to Develop First 3D Bioprinted Human Reconstructed Skin Including Immune Macrophages
Bruker Announces Acquisition of Preclinical and Molecular Imaging Research Software Provider PMOD Technologies, LLC
Rohde & Schwarz and Martin Luther University Halle-Wittenberg Establish Research Partnership
Bruker and Champalimaud Foundation Announce Collaboration to Develop Novel Ultra-High Field 18 Tesla Preclinical MRI System and Applications
Biomedical Software Startup BostonGene Secures M in Series A Financing from NEC
Imec, UZ Leuven, KU Leuven, The Ghent University, Agilent, Western Digital and BlueBee Develop Unique Hybrid Cloud Platform
Digital Revolution - Naval Group, B<>com’s New Industrial Investor
Bruker and the Translational Metabolic Lab At Radboud University Announce the Establishment of A Joint Center of Excellence for Translational Omics
Rohde & Schwarz and Helmut Schmidt University Hamburg Conduct Joint Research
Imec Researcher Receives ERC Advanced Grant to Develop Ultra-bright Thin-film Light Sources and Lasers
DSM Sets Science-based Reduction Targets for Emissions
Novel Nanomaterial Promises Improvements in Batteries and Many More Sustainable Applications

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  La Bella Bakery Artisan Bakery Arizona

Visit  RightITnow, Inc.





 
  ©2020 NewswireToday — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com newswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)